Literature DB >> 12763527

Mouse models for the study of Crohn's disease.

Theresa T Pizarro1, Kristen O Arseneau, Giorgos Bamias, Fabio Cominelli.   

Abstract

Crohn's Disease (CD) is a chronic inflammatory bowel disease (IBD) that can affect any portion of the gastrointestinal tract and can cause significant morbidity. A variety of animal models of both acute and chronic intestinal inflammation have been developed to investigate disease pathogenesis and novel treatment modalities. These include chemically induced, genetically manipulated and immune-mediated models of gut inflammation, each of which possesses similarities to human IBD and offers unique advantages for studying specific aspects of disease pathogenesis. However, the majority of these models are characterized by colitis and, unlike human CD, do not involve the small intestine. More recently, murine models of chronic ileal inflammation have been characterized that spontaneously develop and closely resemble human CD with regard to disease location, histologic features and clinical response to therapy. Two mouse models of experimental ileitis will be discussed in this review: the TNF DeltaARE and SAMP1/YitFc strains. Studies using these new models might provide important insight into the pathogenesis of human CD and test the efficacy of potential therapies to treat this devastating disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763527     DOI: 10.1016/s1471-4914(03)00052-2

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  62 in total

1.  Expression of interleukin 6 in brain and colon of rats with TNBS-induced colitis.

Authors:  Kai Wang; Chuan-Ping Yuan; Wei Wang; Zhan-Qing Yang; Wei Cui; Lian-Zhi Mu; Zhan-Peng Yue; Xiu-Ling Yin; Zhong-Ming Hu; Ju-Xiong Liu
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis.

Authors:  Kai Fang; Megan Bruce; Christopher B Pattillo; Songlin Zhang; Randolph Stone; John Clifford; Christopher G Kevil
Journal:  Physiol Genomics       Date:  2010-10-05       Impact factor: 3.107

Review 3.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

4.  Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.

Authors:  Hamed Laroui; Duke Geem; Bo Xiao; Emilie Viennois; Poonam Rakhya; Timothy Denning; Didier Merlin
Journal:  Mol Ther       Date:  2013-09-12       Impact factor: 11.454

Review 5.  Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger.

Authors:  Charlotte E Egan; Sara B Cohen; Eric Y Denkers
Journal:  Immunol Cell Biol       Date:  2011-11-08       Impact factor: 5.126

6.  Role of interleukin 6 in a murine model of Crohn's ileitis: are cytokine/anticytokine strategies the future for IBD therapies?

Authors:  T T Pizarro; S A De La Rue; F Cominelli
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

7.  Differential angiogenic regulation of experimental colitis.

Authors:  John H Chidlow; Will Langston; James J M Greer; Dmitry Ostanin; Maisoun Abdelbaqi; Jeffery Houghton; Annamalai Senthilkumar; Deepti Shukla; Andrew P Mazar; Matthew B Grisham; Christopher G Kevil
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

8.  Tumor necrosis factor-alpha and interferon-gamma increase PepT1 expression and activity in the human colon carcinoma cell line Caco-2/bbe and in mouse intestine.

Authors:  Stephan R Vavricka; Mark W Musch; Mikihiro Fujiya; Keri Kles; Laura Chang; Jyrki J Eloranta; Gerd A Kullak-Ublick; Ken Drabik; Didier Merlin; Eugene B Chang
Journal:  Pflugers Arch       Date:  2005-11-19       Impact factor: 3.657

9.  Nanoparticle-based therapeutic delivery of prohibitin to the colonic epithelial cells ameliorates acute murine colitis.

Authors:  Arianne L Theiss; Hamed Laroui; Tracy S Obertone; Indrajit Chowdhury; Winston E Thompson; Didier Merlin; Shanthi V Sitaraman
Journal:  Inflamm Bowel Dis       Date:  2010-09-24       Impact factor: 5.325

10.  High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot study.

Authors:  William S Mow; Carol J Landers; A Hillary Steinhart; Brian G Feagan; Ken Croitoru; Ernest Seidman; Gordon R Greenberg; Stephan R Targan
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.